Nanoform launches next-generation STARMAP® v2.0, the AI-based drug candidate selection tool for CESS® |
| March 22, 2021 | March 2021 Bond Updates |
|
HELSINKI, March 22, 2021 /PRNewswire/ -- Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, has today launched the next generation of its STARMAP® AI (artificial intelligence) platform, v2.0. The technology utilizes sparse-data AI to augment experimental results... |
| View more at: https://www.prnewswire.com:443/news-releases/nanoform-launches-next-generation-starmap-v2-0--the-ai-based-drug-candidate-selection-tool-for-cess-301252665.html |
| Related News |